Related Experiment Video
Updated: Jun 9, 2025
09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.3K
Cardiomyopathies: The Role of Non-Coding RNAs
Nicole Carabetta1, Chiara Siracusa1, Isabella Leo2
1Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy.
Non-Coding RNA
|October 25, 2024
Summary
Non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are key regulators in heart muscle disorders. This review analyzes ncRNA patterns in common cardiomyopathies, offering insights into therapeutic targets and disease mechanisms.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Non-coding RNA Research
Background:
- Cardiomyopathies are myocardial structural/functional disorders with complex etiopathogenesis.
- Genetic, environmental, and lifestyle factors contribute to myocardial abnormalities.
- Non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are critical gene expression regulators.
Purpose of the Study:
- To review and analyze the expression patterns of ncRNAs in common cardiomyopathies.
- To explore the role of ncRNAs in the molecular mechanisms underlying cardiomyopathies.
- To identify potential therapeutic targets and risk stratification models based on ncRNA expression.
Main Methods:
- Literature review and analysis of existing studies on ncRNAs in cardiomyopathies.
- Focus on dilated cardiomyopathy, hypertrophic cardiomyopathy, and arrhythmogenic cardiomyopathy.
- Examination of gene expression patterns related to ncRNAs.
Main Results:
- ncRNAs play a significant role in the pathogenesis of common cardiomyopathies.
- Specific ncRNA expression patterns are associated with different types of cardiomyopathy.
- Understanding these patterns can illuminate disease mechanisms.
Conclusions:
- Analysis of ncRNAs provides valuable insights into cardiomyopathy development.
- ncRNAs represent potential targets for novel therapeutic strategies.
- ncRNA profiling may aid in risk stratification and personalized medicine for cardiomyopathies.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
1
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
1
01:20Types of RNA
5.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.7K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
1
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
1
01:13Formation of Muscle Fibers from Myoblasts
4.8K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.8K
01:29Cardiomyopathy V: Interprofessional Care
1
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
1